Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9558b14b5dbbec9f412b86c9304eb536 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2014-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42b0f3724a0ba78735f831df410d5c83 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f30c2967001ee373da0e1c903cfaea74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7304ab509b07fdeebcca42b6a753e5c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bd7d41f1891eb735254eadcfec14390 |
publicationDate |
2014-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-104013951-A |
titleOfInvention |
Nitric Oxide Donor Type Glutathione Compound Injection and Its Application |
abstract |
The invention discloses a nitric oxide donor type glutathione compound injection, a preparation method and its application in the preparation of anti-cancer drugs. The invention prepares a safe and stable compound I injection; the solvent is prepared first, and then the compound I is prepared The method of the solution ensures the quality of the injection, and the safety experiment shows that the intravenous infusion of the injection will not cause allergic reactions and blood vessel irritation reactions, and no aggregation and hemolysis phenomenon have been seen, showing that the injection is safe for clinical intravenous administration. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105106930-A |
priorityDate |
2014-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |